Business Wire·Nov 9, 2026, 4:05 PM ET

Hims & Hers Health, Inc. Reports Third Quarter 2026 Financial Results

Hims & Hers Health, Inc. reported third-quarter 2026 revenue of approximately $890 million, representing a 49% increase year-over-year.
Subscribers grew to nearly 2.8 million, a 13% increase year-over-year, with monthly revenue per average subscriber rising 30% to $105.
Domestic revenue increased 21% year-over-year, while international revenue surged more than 300% year-over-year.
Gross margin decreased to 57% for the third quarter of 2026 compared to 74% in the same period of 2025.
The company reported a net loss of $33.0 million for the third quarter of 2026, contrasting with net income of $15.8 million in the prior year period.
Adjusted EBITDA for the quarter was $82.4 million, up from $78.4 million in the third quarter of 2025.
Free cash flow for the quarter was $26.0 million, a decrease from $79.4 million in the same period of 2025.
Full-year 2026 revenue guidance was tightened to a range of $3.13 billion to $3.15 billion.
Full-year 2026 Adjusted EBITDA guidance was reduced to a range of $257 million to $277 million.
The company plans to pace marketing spend ahead of planned platform expansions in the fourth quarter of 2026.
Hims & Hers will host a conference call to discuss results on November 9, 2026, at 5:00 p.m. ET.
Cash and cash equivalents at the end of the third quarter were $605.6 million, up from $228.6 million at the end of 2025.